Health & Medications

A Warm GLP-1 Delivery Is a Question for the Pharmacy

By Priya Lindqvist / October 17, 2026 / Updated November 8, 2026

Man in a white coat speaking toward a video camera with his face visible

You open a medicine delivery and the package feels warm, the cooling materials look too thin, or the label leaves you unsure what you received. It is reasonable to want an answer before you use anything. The U.S. Food and Drug Administration (FDA) says patients should not use an injectable GLP-1 medicine that arrives warm or without enough refrigeration. This guide explains what to keep, who to ask, what two manufacturers publish about storage, and why the supplier matters. GLP-1 is shorthand for a family of medicines that includes semaglutide and tirzepatide, which FDA’s page discusses. This is general information, not medical advice.

Key takeaways

FDA’s page, current as of October 1, 2026, says it has received complaints of GLP-1 drugs arriving warm or with too little ice, and that patients should not use an injectable that arrives that way.
Keep the packaging, labels, delivery time and photographs, and contact the dispensing pharmacy using details you found yourself.
Storage limits are different for each product. The figures in this guide come from two manufacturers’ pages and describe storage by the patient, not a ruling on your delivery.
Do not double a dose, change your schedule or use someone else’s supply. Ask your pharmacist or prescriber.
FDA advises getting a prescription and using a state-licensed pharmacy, and says compounded drugs are not FDA approved.

What FDA says about a warm delivery

FDA’s page “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss” says injectable GLP-1 drugs need refrigeration. It reports complaints of drugs arriving warm or with too little ice, and tells patients not to use an injectable that arrives warm or insufficiently refrigerated. The page is current as of October 1, 2026.

Putting a warm package into the refrigerator afterward cannot tell you what happened during the trip. That is why the answer should come from the pharmacy, based on the product you received. A friend’s experience with another product is not a safe guide.

A word about terms. A compounded drug is one prepared by a pharmacy or outsourcing facility rather than being the manufacturer’s FDA-approved product. FDA says compounded drugs are not approved, and that it does not check their safety, effectiveness or quality before they reach the market.

Keep the delivery details together

Before you throw anything away, collect what will help the pharmacy understand what happened. These records do not tell you whether the medicine is usable. They give the pharmacy a clear account.

Write down the date and time the package arrived and when you opened it.
Keep the shipping label, the product label and any storage instructions.
Take photographs of the box, the cooling materials and the medicine, especially if anything is damaged or instructions are missing.
Keep the packaging. Novo Nordisk’s pen page says that if a pen has an issue, you should keep the pen and its packaging and contact the company before throwing it away.
Note the name of anyone you speak with, the date, and any case number they give you.

Keep your prescription details private. A public social media post is not a substitute for contacting the people responsible for the medicine.

Who to ask, and what to ask

Start with the dispensing pharmacy, the one named on the label. Use a phone number or website you have checked yourself, such as the one on your prescription label or your insurance card, rather than one in a message sent to you.

Describe the condition of the package and when it arrived.
Ask what to do with the medicine while the problem is reviewed.
Ask for an answer about the specific product you received, not general advice about a different pen or vial.
Ask whether the pharmacy wants photographs, and how you can follow up on your case.
Ask how replacement or refund questions are handled. This guide cannot promise either one.
If the label or the delivery still seems unclear, tell your prescribing clinician what is unresolved.

What manufacturers publish about storage

Storage rules are written for each product. The table shows what two manufacturers publish for one type of product each, as examples. These are not recommendations, and other products, including compounded ones, may differ. The figures also describe how the patient stores the medicine. They do not say how a package that arrived warm should be treated, so they cannot settle your question.

Source and product	Refrigerator	Room temperature allowance	Other notes
Lilly USA, Zepbound single-dose pen	36 to 46 degrees F (2 to 8 degrees C); do not freeze	Up to 86 degrees F (30 degrees C) for up to 21 days	Do not return it to the refrigerator after room-temperature storage. Keep it in the carton. Do not use it if it has been frozen, is cloudy or discolored, has particles, or is past its expiration date.
Novo Nordisk, Wegovy pen	36 to 46 degrees F (2 to 8 degrees C); do not freeze	46 to 86 degrees F (8 to 30 degrees C) for up to 28 days, “if needed”, before the cap is removed	Keep the cap on until use. Keep the pen in its carton to protect it from light. Discard it if it has been frozen.

For multi-dose vials, FDA’s GLP-1 page says to discard a vial 28 days after first use, even if medicine remains, and to use a new sterile needle and syringe for each dose. Ask your pharmacist which instructions apply to your product. The manufacturer figures above were checked in November 2026, and manufacturers can change them.

Delays, missed doses and dosing questions

A delivery problem can disturb your usual schedule. If the delay affects when you would normally take your medicine, ask your prescriber or pharmacist what to do. Do not make up for it by doubling a dose, changing the schedule yourself or using someone else’s supply. The right answer depends on your prescription and your situation.

FDA’s page also describes reports of dosing errors, some leading to hospital stays. They involved patients measuring doses incorrectly and clinicians miscalculating, as well as people taking more than the label says, taking doses more often, or raising the dose faster. The symptoms FDA lists include nausea, vomiting, diarrhea, abdominal pain and constipation. If you are unsure how to measure or give your medicine, ask your pharmacist to go through it with you.

Why the supplier matters

A reassuring label does not make a supplier accountable. FDA advises getting a prescription from your doctor and filling it at a state-licensed pharmacy. In its page on compounding, FDA says state boards of pharmacy generally oversee state-licensed pharmacies, and that compounded drugs should be used only when an approved drug cannot meet a patient’s medical need. It also recommends researching an online pharmacy or telehealth service first, since you may not know who made the drug.

FDA’s GLP-1 page lists red flags with telehealth sellers. It also warns that some fraudulent labels name pharmacies that do not exist, and that some products sold for human use are labeled “for research purposes”. Use this checklist:

A claim that a compounded drug is the same as an approved one.
An unusually low price.
Mismatched or damaged products or labels.
No screening or follow-up by a licensed doctor.
Spelling errors, or a pharmacy address that does not match.

The practical goal is to know who dispensed the medicine and who will answer for a concern. FDA also points to its BeSafeRx resources for buying prescription medicine online.

Reporting a problem

If you have a bad reaction or suspect a quality problem, get appropriate medical help first. Then consider a report through FDA’s MedWatch program, which accepts reports from patients and consumers through an online form. As of May 31, 2026, FDA said it had received 990 reports for compounded semaglutide and more than 730 for compounded tirzepatide. FDA notes these are probably under-reported and that it cannot always confirm cause.

Frequently asked questions

Is it safe to use if it arrived warm?

FDA says patients should not use an injectable GLP-1 drug that arrives warm or without adequate refrigeration, because its quality may be affected. Contact the dispensing pharmacy and your prescriber before doing anything else.

Can I put it in the refrigerator and use it anyway?

That is a question for your pharmacist. A refrigerator cannot show what happened during shipping, and the manufacturer’s storage allowances do not describe a warm delivery.

How long can a pen be out of the refrigerator?

It depends on the product. The pages cited above give 21 days for one single-dose pen and 28 days for another pen, under conditions the makers set. Check your own product’s instructions and ask your pharmacist.

What is the difference between a compounded and an approved drug?

An approved drug has been reviewed by FDA. FDA says compounded drugs have not been approved and are not checked for safety, effectiveness or quality before they reach the market.

Before you decide

When a delivery looks wrong, slow down and gather the facts first. Keep the packaging, take photographs, and contact the dispensing pharmacy through a number you trust. Do not change your dose or schedule on your own. Ask your pharmacist or prescriber what to do about the medicine and your next dose.